An update on publicly funded multisite trials in pediatric psychopharmacology

Benedetto Vitiello

Research output: Contribution to journalReview articlepeer-review

Abstract

In the last 10 years, the National Institute of Mental Health has funded a number of multisite clinical trials in pediatric psychopharmacology. Trials have been completed or are in progress in attention-deficit hyperactivity disorder, depression, autism, schizophrenia, bipolar disorder, obsessive-compulsive disorder, and other anxiety disorders. Direct comparison between different treatment modalities, such as pharmacotherapy and psychotherapy, alone or in combination, has been the focus of a number of these studies, to inform clinicians and families of the relative therapeutic benefits of alternative interventions. This article presents a brief overview of these studies.

Original languageEnglish (US)
Pages (from-to)1-12
Number of pages12
JournalChild and Adolescent Psychiatric Clinics of North America
Volume15
Issue number1
DOIs
StatePublished - Jan 2006

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Psychiatry and Mental health

Fingerprint

Dive into the research topics of 'An update on publicly funded multisite trials in pediatric psychopharmacology'. Together they form a unique fingerprint.

Cite this